(1).- “A Novel Coronavirus from Patients with Pneumonia in China, 2019”. Na Zhu, Dingyu Zhang , Wenling Wang, Xingwang Li, Bo Yang, Jingdong Song, Xiang Zhao, Baoying Huang, Weifeng Shi, Roujian Lu, Peihua Niu, Faxian Zhan, Xuejun Ma, Dayan Wang, Wenbo Xu, Guizhen Wu, George F Gao & Wenjie Tan. A Novel Coronavirus from Patients with Pneumonia in China, 2019

(2).- “Logran secuenciar el genoma del virus SARS-CoV-2 en dos pacientes en Barcelona”.

(3).- “De regreso a Wuhan un año después del primer encierro mundial por la Covid” NBC. Enero 2021.

(4).- “The protein expression profile of ACE2 in human tissues”. Hikmet, F. et al. Molecular Systems Biology.

(5).- EMA. Summary of Product Characteristics.

(6).- FDA. Briefing Document.

(7).- «Un experto en enfermedades infecciosas pide precaución sobre la vacuna de Pfizer contra el coronavirus«

(8) Carta de los Dres. Peter Doshi y Juan Gérvas al director del New England Journal of Medicine titulada “Exposición sesgada de los resultados en el “Abstract” y el “Reseachr Summary” del estudio publicado de la vacuna de Pfizer (Vacuna BNT162b2 mRNA Covid-19). Acta Médica.

(9) “Pfizer and Moderna’s “95% effective” vaccines—we need more details and the raw data”. Peter Doshi. Brithis Medical Journal.

(10) “COVID-19 vaccine efficacy and effectiveness—the elephant (not)in the room” Piero Olliaro, Els Torreele y Michel Vaillant. The Lancet.

(11) Portal oficial de la Junta de Extremadura

(12) Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—we need more details and the raw data.

(13) Evaluating covid-19 vaccine efficacy and safety in the post-authorisation phase.

(14)BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.

(15) Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents.

(16) Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study.

 (17) Covid-19: Norway investigates 23 deaths in frail elderly patients after vaccination.

(18) Pfizer. SARS-CoV-2 mRNA Vaccine (BNT162, PF-07302048). Summary of pharmacokinetic study.

(19) Extrapulmonary manifestations of COVID-19, https://pubmed.ncbi.nlm.nih.gov/32651579/

(20) A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination.

(21) “Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons”. Tom T. Shimabukuro, M.D. et all. June 17, 2021. The New England Journal of Medicine.